Navigation Links
What U.S. Doctors Know That Has Not Yet Reached China
Date:10/22/2013

NEW YORK, Oct. 22, 2013 /PRNewswire/ -- Fibromyalgia (FM), a disorder now taken seriously in the United States after decades of misinformation and misdiagnosis, is still largely misunderstood and underdiagnosed by physicians in China. A recent national survey of Chinese rheumatologists revealed they have a lower awareness of FM compared with colleagues in Western countries. Sadly for China's patients with FM—a chronic disorder characterized by widespread musculoskeletal pain and fatigue—the dismissive attitude formerly directed at U.S. patients ("It's all in your mind!") is now being encountered by Chinese patients, just before they walk out of the doctor's office with no relief in sight.

An anonymous survey was conducted among a nationwide sample of Chinese rheumatologists at the 15th National Rheumatology Conference in 2010, with results published in the International Journal of Rheumatic Diseases this year. Of more than 700 respondents, 80 percent reported difficulties in treating FM patients. Nearly all—90.8 percent—mistakenly believed that the prognosis of FM patients was usually benign, and nearly 30 percent believed FM was only a psychological disorder. The investigators concluded that "awareness and perception of FM are still low among Chinese rheumatologists." There was some good news from the survey, however: "Our data also showed that most Chinese rheumatologists were eager for continuing medical education on FM."

In the U.S., people with FM who complained of "pain all over their bodies, constant fatigue and poor sleep" are no longer being told all they have is a psychological condition. Thanks to advanced medical technologies, most doctors here—both rheumatologists and other specialists—now have a deeper understanding as to how FM affects the body. However, with five million affected people in the U.S., the challenge is that treatment remains elusive. And there are still outstanding challenges as only half of this population is being treated.

Enter Seth Lederman, M.D., President and CEO of NYC-based TONIX Pharmaceuticals. The company's formulation, TNX-102 SL, is designed to help change FM treatment for millions of sufferers. Dr. Lederman and his team believe the key to easing the pain and suffering is enabling these patients to break the vicious cycle between poor sleep at night and pain during the day.

TONIX has taken cyclobenzaprine—an FDA-approved muscle relaxant that's been on the market for 35 years—and reformulated it as an under-the-tongue tablet taken at bedtime. This allows cyclobenzaprine to be taken up into the bloodstream rapidly, setting the tone for restorative sleep, which has been shown to mitigate pain experienced in FM.

Tonix recently announced the initiation of its Bedtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT) clinical trial, which is the first of two pivotal trials for TNX-102 SL 2.8 mg tablets, in patients with FM. 

For more on TNX-102 SL and the BESTFIT trial, visit www.tonixpharma.com.

Contact:  Laura Radocaj, Dian Griesel Int'l., 212.825.3210


'/>"/>
SOURCE TONIX Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Scripps Doctors Study Novel New Device to Diagnose Irregular Heart Beat
2. Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online
3. Doctors at St. Josephs Hospital Stopping Atrial Fibrillation Cold
4. New Program Has Doctors, Patients Learn Together As Traditional Relationship Changes Forever
5. Eaton Scientific Discusses Positive Anecdotal Feedback from Pharmacist Compounding Homatropine for Doctors Treating Patients Experiencing Hot Flash Symptoms in the Beverley Hills and Los Angeles Area.
6. Latest Trend in Drug Manufacturer Sales Allows Doctors to Obtain Product Samples Online
7. Africa Needs Engineers as Much as Doctors to Save Lives, says South African Entrepreneur
8. Africa Needs Engineers as Much as Doctors to Save Lives, says South African Industrialist
9. The Japanese Cancer Association and Debiopharm Group Present Doctors Oshima and Tanaka with the 2012 JCA-Mauvernay Award for their Innovative and Outstanding Cancer Research
10. WebMD Study: U.S. Doctors Deeply Divided on Many Matters of Ethical Ambiguity
11. For Drug Manufacturers Bringing a New Product to Market, Gaining the Support of Influential Doctors Is a Mission-Critical Priority
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):